ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]

RxCUI
1293864
RxNorm name
ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]
Display name
ERGOMAR (Sublingual)
Full name
ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]
Term type
SBD
Status
Active
Strength
2 mg
Dose form
Tab
Route
Sublingual
Updated
2026-10-30 15:30:34

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062012
Active start
062012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ergotamine tartrate2 MG / 1 EACHergotamineergotamine tartrate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Sublingual Tablet317007

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ergotamine4025

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRErgomar 2 MG Sublingual Tablet1NAMES
RxNorm Nameergotamine tartrate 2 MG Sublingual Tablet [Ergomar]1NAMES
RxNorm SynonymErgomar 2 MG Sublingual Tablet1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_IDa9582fdb-7ddd-4f69-aa7a-66247cdb8c921CODES
RxCUI12938641CODES
MMSL_CODEBD36981CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
81279-104-0381279-104Ergomar Ergotamine TartratePangea Pharmaceuticals LLCANDA087693
81279-104-2081279-104Ergomar Ergotamine TartratePangea Pharmaceuticals LLCANDA087693

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA08769381279-104Ergomar Ergotamine TartrateANDAPangea Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 11 matching rows.

NDC11, Source, Active table
NDC11SourceActive
70720012020rxnav_ndcsyes
81279010403rxnav_ndcsyes
81279010420rxnav_ndcsyes
10802120200rxnav_historical
10802120202rxnav_historical
10802120203rxnav_historical
59417012003rxnav_historical_indirect
59417012020rxnav_historical_indirect
67754012002rxnav_historical
67754012020rxnav_historical
70720012003rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ergomar SublingualERGOTAMINE TARTRATEPangea Pharmaceuticals LLCa9582fdb-7ddd-4f69-aa7a-66247cdb8c922025-02-25Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 81279-104-03
ndc (package): 81279-104-20
ndc (product): 81279-104
ndc11 (package): 81279010420
ndc11 (package): 81279010403
rxcui: 1293864

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a9582fdb-7ddd-4f69-aa7a-66247cdb8c92Ergomar 2 MG Sublingual Tablet [PSN] · ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] [SBD] · Ergomar 2 MG Sublingual Tablet [SY]32Ergomar ® Sublingual Tablets, 2 mg20250225

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
dac9637f-3326-4f25-b7b9-f9f54b738232Ergomar ® Sublingual Tablets, 2 mgTerSera Therapeutics, LLC | Mikart, LLC20250410
a9582fdb-7ddd-4f69-aa7a-66247cdb8c92Ergomar ® Sublingual Tablets, 2 mgPangea Pharmaceuticals LLC | Mikart, LLC20250225
f55ef9b6-3068-4c8c-aa5d-920fea54ceb4National Council for Prescription Drug Programs20130213
1bfd4827-5123-4dbb-8f94-7b097f5bfd5cErgomar® Sublingual Tablets, 2 mg (Ergotamine Tartrate Sublingual Tablets, USP)Rosedale Therapeutics | Mikart, Inc.20120908

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02CAErgot alkaloidsATC1-4ergotamine
FDASPLD004879ErgotaminesCHEMhas_chemical_structureergotamine
FDASPLN0000175766Ergotamine DerivativeEPChas_epcergotamine
MEDRTD001393AzolesCHEMci_chemclassergotamine
MEDRTD001393AzolesCHEMci_chemclassergotamine tartrate
MEDRTD002219CarbamatesCHEMci_chemclassergotamine tartrate
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine tartrate
MEDRTD005663FuransCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine
MEDRTD019888NelfinavirCHEMci_chemclassergotamine tartrate
MEDRTD019438RitonavirCHEMci_chemclassergotamine tartrate
MEDRTD013449SulfonamidesCHEMci_chemclassergotamine tartrate
MEDRTD000033Abortion, ThreatenedDISEASEci_withergotamine tartrate
MEDRTD000788Angina Pectoris, VariantDISEASEmay_diagnoseergotamine tartrate
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine tartrate
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine tartrate
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine tartrate
MEDRTD006973HypertensionDISEASEci_withergotamine
MEDRTD006973HypertensionDISEASEci_withergotamine tartrate
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine tartrate
MEDRTD008107Liver DiseasesDISEASEci_withergotamine tartrate
MEDRTD008107Liver DiseasesDISEASEci_withergotamine
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine tartrate
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine tartrate
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine
MEDRTD006473Postpartum HemorrhageDISEASEmay_preventergotamine tartrate
MEDRTD006473Postpartum HemorrhageDISEASEmay_treatergotamine tartrate
MEDRTD011247PregnancyDISEASEci_withergotamine
MEDRTD011247PregnancyDISEASEci_withergotamine tartrate
MEDRTD018805SepsisDISEASEci_withergotamine
MEDRTD018805SepsisDISEASEci_withergotamine tartrate
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine tartrate
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine tartrate
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine tartrate
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine tartrate
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine tartrate
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000008376Cutaneous Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine tartrate
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH2 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA087693
NAMESPrescribable SynonymErgomar 2 MG Sublingual Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon